Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
06/02/2010 | CN101182469B Aspergillus niger strain having highly-resistant activity to carbendazol and uses thereof |
06/02/2010 | CN101182468B Trichoderma epiphyte having nematicidal activity as well as preparation method and uses thereof |
06/02/2010 | CN101182418B Biological modification method for sand desertification soil |
06/02/2010 | CN101143902B Anti-HER2 single-chain antibody-cefuroxime sodium enhanced fusion protein HER2(Fv-LDM) |
06/02/2010 | CN101143002B Deep liquid fermentation method for preparing selenium-rich gold needle mushroom crude polysaccharide powder |
06/02/2010 | CN101085989B Process for producing tomatine using bacteria fermentation |
06/02/2010 | CN101085449B Deodorization method for town refuse biology re-fermentation |
06/02/2010 | CN101018856B Selective culture method and isolation method of small hepatocytes with hialuronic acid |
06/01/2010 | US7727754 Nucleotide sequences coding cellulase for use in textile treatment, cleaning products and production of ethanol |
06/01/2010 | US7727718 Reagents for storage and preparation of samples for DNA analysis |
06/01/2010 | US7727572 food products such as doughs and dairy products, animal feed, pharmaceuticals, cosmetics, dental care products |
06/01/2010 | CA2442679C Methods for secretory production of proteins |
06/01/2010 | CA2336221C Human neuronal acid-sensitive cationic channels, its cloning and applications |
06/01/2010 | CA2309925C Recombinant vaccines comprising immunogenic attenuated bacteria having rpos positive phenotype |
06/01/2010 | CA2288373C Human cerberus protein |
06/01/2010 | CA2212577C Bacillus proteases |
06/01/2010 | CA2157427C Oxazoloquinolinone derivatives, their preparation and their therapeutic application |
05/27/2010 | WO2010060085A2 Apparatus and method for treatment of microorganisms during sugar production and sugar-based fermentation processes |
05/27/2010 | WO2010059626A1 Filamentous fungi with impaired ptrb activity for altered protein production |
05/27/2010 | WO2010059616A2 Biocatalysts and methods for conversion of hemicellulose hydrolsates to biobased products |
05/27/2010 | WO2010059539A2 Genetically engineered yeast for the production of biofuels |
05/27/2010 | WO2010059095A1 Saccharomyces strain with ability to grow on pentose sugars under anaerobic cultivation conditions |
05/27/2010 | WO2010059028A1 Bacteria for the degradation and modification of fats, oils and grease |
05/27/2010 | WO2010059022A1 Method for obtaining a mixture of probiotics, nutrient prebiotics having synergistic symbiotic action |
05/27/2010 | WO2010058707A1 Fusion collagenase to which affinity tag is attached, and method for producing same |
05/27/2010 | WO2010058616A1 Method for production of glutamic acid-rich yeast |
05/27/2010 | WO2010058558A1 Method for producing alanine-rich yeast |
05/27/2010 | WO2010058551A1 Method for producing amino-acid-rich yeast |
05/27/2010 | WO2010058527A1 Method for producing yeast with high glutamic acid content |
05/27/2010 | WO2010058427A2 Process for production and purification of polymyxin b sulfate |
05/27/2010 | WO2010058294A1 Blood-cholesterol-lowering strain of lactobacillus delbrueckii |
05/27/2010 | WO2010057985A2 Salmonella marker vaccine |
05/27/2010 | WO2010027516A3 Transgenically preventing establishment and spread of transgenic algae in natural ecosystems |
05/27/2010 | WO2010006312A3 Methods and compositions for producing carbon-based products in microorganisms |
05/27/2010 | WO2009151728A3 Microorganisms for the production of adipic acid and other compounds |
05/27/2010 | US20100132073 Sesquiterpenoid modifying enzymes |
05/27/2010 | US20100132069 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants |
05/27/2010 | US20100130443 Chitosan derivatives, compositions and related methods of use |
05/27/2010 | US20100130433 Casein-Derived Peptides having Anxiolytic Activity |
05/27/2010 | US20100130417 Transforming growth factor alpha hii |
05/27/2010 | US20100129916 Expression of Toxic Genes In Vivo in a Non-Natural Host |
05/27/2010 | US20100129904 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); for treating cancer responsive to interferon alpha therapy |
05/27/2010 | US20100129901 Hepatitis c virus vaccine |
05/27/2010 | US20100129892 Process for the preparation of 1,3-propanediol by a recombinant micro-organism in the absence of coenzyme b12 or one of its precursors |
05/27/2010 | US20100129889 Affinity separation methods and systems |
05/27/2010 | US20100129887 Increased production of isobutanol in yeast with reduced mitochondrial amino acid biosynthesis |
05/27/2010 | US20100129886 Production of isobutanol in yeast mitochondria |
05/27/2010 | US20100129885 Methods for the production of n-butanol |
05/27/2010 | US20100129884 Process for Producing Fermentation Product from Carbon Sources Containing Glycerol using Corynebacteria |
05/27/2010 | US20100129883 Substrate-selective co-fermentation process |
05/27/2010 | US20100129867 Method for producing dipeptide |
05/27/2010 | US20100129866 Method for production of dipeptide |
05/27/2010 | US20100129865 Ketose 3-epimerase, its preparation and uses |
05/27/2010 | US20100129864 Novel Bacteriocins, Transport and Vector System and Method of Use Thereof |
05/27/2010 | US20100129862 Novel lipolytic Enzyme lip1 |
05/27/2010 | US20100129857 Methods for the isolation and identification of microorganisms |
05/27/2010 | US20100129827 Method and device for sample preparation control |
05/27/2010 | US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues |
05/27/2010 | US20100129813 Compositions and methods for detecting food-borne pathogens |
05/27/2010 | US20100129491 Tryptophan transporter gene and use thereof |
05/27/2010 | US20100129408 Klebsiella pneumoniae attenuated virulence mutant and method of production |
05/27/2010 | US20100129407 Tuberculosis Vaccine |
05/27/2010 | US20100129406 Holin-enhanced vaccines and reagents, and methods of use thereof |
05/27/2010 | US20100129396 V. cholerae hyperexpressing recombinant cholera toxin b subunit showing dual immunogenicity |
05/27/2010 | US20100129381 Nucleotide sequences coding fibroblast growth factor-19 specific immunoglobulin for use in prevention and treatment of tumors, cancer and/or cell proliferative disorders |
05/27/2010 | US20100129374 Mammalian Cell Membrane Proteins; Related Reagents |
05/27/2010 | US20100129349 Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus |
05/27/2010 | US20100129337 Selection and use of lactic acid bacteria for reducing inflammation caused by Helicobacter |
05/27/2010 | US20100129336 Stabilized bacterial formulation |
05/27/2010 | US20100129333 Anti-fatty liver agent |
05/27/2010 | US20100129323 Novel Shuttle Vector |
05/27/2010 | US20100129322 Tetracycline-sensitive bifidobacteria strains |
05/27/2010 | CA2744495A1 Yeast expressing cellulases for simultaneous saccharification and fermentation using cellulose |
05/27/2010 | CA2744426A1 Polypeptide |
05/27/2010 | CA2744286A1 Fusion collagenase in which affinity tag is linked and method for producing the same |
05/27/2010 | CA2744251A1 Salmonella marker vaccine |
05/27/2010 | CA2743634A1 Filamentous fungi with impaired ptrb activity for altered protein production |
05/26/2010 | EP2189542A1 Lactic acid bacteria strains exhibiting probiotic properties and compositions comprising the same |
05/26/2010 | EP2189531A1 Novel dna fragment, recombinant vector containing the same, transformant transformed therewith and utilization of the same |
05/26/2010 | EP2189528A1 Fluorescent protein with deep blue color |
05/26/2010 | EP2189525A1 Hybrid alpha-glucoside transporter |
05/26/2010 | EP2189521A1 Lactic acid bacteria and their cellular components inducing immunoregulatory function, and method of obtaining the same |
05/26/2010 | EP2189520A1 Cell isolation method |
05/26/2010 | EP2189475A2 Fibroblast growth factor-like polypeptides |
05/26/2010 | EP2189422A1 Activated sludge material, reduction method of excess sludge amount in bioreactor, and maintenance method of bioreactor |
05/26/2010 | EP2189164A1 Salmonella marker vaccine |
05/26/2010 | EP2188377A1 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type i interferon response |
05/26/2010 | EP2188376A2 Molecule production by photosynthetic organisms |
05/26/2010 | EP2188366A1 Human specific escherichia coli strains |
05/26/2010 | EP2187958A1 Attenuated ehrlichiosis vaccine |
05/26/2010 | EP1664292B1 Animal product free media and processes for obtaining a botulinum toxin |
05/26/2010 | EP1660650B1 Improved sso7-polymerase conjugate proteins |
05/26/2010 | EP1599596B1 Combinatorial dna library for producing modified n -glycans in lower eukaryotes |
05/26/2010 | EP1539945B1 Recombinant type ii restriction endonucleases, mmei and related endonucleases and methods for producing the same |
05/26/2010 | EP1290194B1 Production of secreted polypeptides |
05/26/2010 | EP1144642B1 Compounds and methods for treatment and diagnosis of chlamydial infection |
05/26/2010 | CN1989238B Succinic acid-producing bacterium and process for producing succinic acid |
05/26/2010 | CN1952106B Avirulent binucleate rhizoctonia BNR-1 agricultural agent and its uses |
05/26/2010 | CN1934241B Bacillus subtilis strain having antagonistic activity for controling plant diseases |
05/26/2010 | CN1912111B Engomphosis and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen |